capital raising

(NASDAQ:WAY) LEHI, Utah, and LOUISVILLE, Ky., Sept. 11, 2025 /PRNewswire/ -- Waystar Holding Corp. (Nasdaq: WAY) ("Waystar"), a provider of leading healthcare payments software, today announced the pricing of the previously announced underwritten secondary offering by certain investment funds of EQT...

(NASDAQ:VERI) DENVER--(BUSINESS WIRE)--Veritone, Inc. (NASDAQ: VERI), a leader in building human-centered enterprise AI solutions, today announced the pricing of an underwritten public offering of 9,505,705 shares of its common stock. The shares of common stock are being sold at a public offering price of $2.63 per share. The aggregate gross proceeds to Veritone from this offering are expected to be approximately $25 million, before deducting underwriting discounts and commissions and other estimated offerin

MALVERN, Pa., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that it has entered into a securities purchase agreement with Janus Henderson Investors, a global asset management firm, to purchase 20,000,000 shares of common stock and warrants to purchase up to an aggregate of 20,000,000 shares of common stock at a purchase price of $1.00 per share (closing price on August 7, 2025) and accompanying warrant in a registered direct offering. The warrants have an exercise price of $1.50 per share, are exercisable immediately upon issuance, and will expire two years following the date of issuance. The warrants are callable by the Company when the VWAP of the Company’s common stock exceeds $2.50 per share for at least five of a trailing 30 trading day period.